PreludeDx
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
26051 Merit Cir Ste 103, Laguna Hills, C...Phone Number
(888) 211-3247Website
www.preludedx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
2
1
1
About PreludeDx
PreludeDx is a leading personalized breast cancer diagnostics company dedicated to serving breast cancer patients and physicians worldwide. Founded in 2009 with technology licensed from the University of California San Francisco, PreludeDx has focused on developing precision breast cancer tools that will impact a patient's treatment decision. The company's mission is to provide patients and physicians with innovative technologies that improve patient outcomes and reduce the overall cost burden to the healthcare system.Explore more
PreludeDx Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PreludeDx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on PreludeDx recently announced quarterly report
Product Launch: Get notified when PreludeDx launches new products
Check out if PreludeDx is spiking on competitors!
Funding: Get notified immidiatlly once PreludeDx has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PreludeDx had a recent Job posting/layoffs
PreludeDx, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at PreludeDx
Website visits: Recent activity has been detected on your website
Check if PreludeDx has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to PreludeDx
Compare insights from companies similar to PreludeDx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PreludeDx is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PreludeDx is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PreludeDx.
PreludeDx financials insights
Gather financial insights about PreludeDx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2022
Other Financing Round
$20M
PreludeDx Tech Stack
A closer look at the technologies used by PreludeDx
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Executive Moves, New Hire
Open Position
Open Position
PreludeDx News & Media
PreludeDx Announces Publication in Breast Cancer Research Validating AidaBreast™, the Only Multi-Omic Test to Predict Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer
LAGUNA HILLS, Calif., March 12, 2026 /PRNewswire/ -- Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today the publication of results from a large, multi-institutional validation study of the AidaBreast™ test in Breast Cancer...PreludeDx Appoints MiMi Reyes as Senior Executive Management Team to Support Growth Initiatives
LAGUNA HILLS, Calif., Jan. 22, 2026 /PRNewswire/ -- Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced the appointment of MiMi Reyes as Senior Vice President of Operations. Reyes is a seasoned diagnostics and medical device...PreludeDx Announces First Independent Validation of AidaBreast™, the Only Multi-Omic Test to Predict Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer
LAGUNA HILLS, Calif., Dec. 10, 2025 /PRNewswire/ -- Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced results from the first independent validation of AidaBreast™, a novel multi-omic biosignature developed to predict a...PreludeDx Study Demonstrates Superiority of DCISionRT® Over Clinicopathology Factors and Criteria for DCIS Treatment Management
LAGUNA HILLS, Calif., July 31, 2025 /PRNewswire/ -- PreludeDx™, a leader in breast cancer precision diagnostics, today announced the publication of new groundbreaking data in the International Journal of Radiation Oncology• Biology• Physics ("Red Journal"). The study demonstrated that...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding PreludeDx
Sign Up For FreeTo access detailed company insights
PreludeDx is a leading personalized breast cancer diagnostics company dedicated to serving breast cancer patients and physicians worldwide. Founded in 2009 with technology licensed from the University of California San Francisco, PreludeDx has focused on developing precision breast cancer tools that will impact a patient's treatment decision. The c... Read More
